Health Sciences Group, Inc.
HESGOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$1870936
P/E Ratio—
52W High$0.0001
52W Low$0.000001
Health Sciences Group, Inc. (HESG) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · HESG · as of 2026-06-15
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2012-12 | 2005-12 | 2004-12 | 2003-12 | 2002-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.36M | $0.06M | $0.07M | $5.37M | $5.54M |
| Cost of Revenue | $0.33M | $0.04M | $0.02M | $4.37M | $4.05M |
| Gross Profit | $0.03M | $0.02M | $0.05M | $1.00M | $1.49M |
| Gross Margin %(computed) | 7.04% | 38.10% | 69.44% | 18.61% | 26.89% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.06M | $0.01M | $0.05M | $0.05M |
| G&A Expenses | $0.00M | $5.53M | $4.39M | $0.00M | $0.00M |
| Total Operating Expenses | $0.08M | $7.50M | $4.59M | $4.80M | $5.57M |
| Operating Income | ($0.05M) | ($7.48M) | ($4.55M) | ($3.80M) | ($4.08M) |
| Operating Margin %(computed) | -15.20% | — | — | -70.89% | -73.67% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($0.05M) | ($5.58M) | ($5.44M) | ($5.36M) | ($4.28M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($0.05M) | ($5.75M) | ($10.45M) | ($7.42M) | ($4.28M) |
| Net Margin %(computed) | -15.20% | — | — | -138.29% | -77.36% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.03 | $-0.25 | $-0.78 | $-0.76 | $-0.73 |
| Wtd Avg Shares | 1.87M | 24.56M | 14.13M | 11.10M | 5.83M |
| EBITDA | ($0.04M) | ($4.97M) | ($3.29M) | ($2.32M) | ($3.77M) |
| EBITDA Margin %(computed) | -12.48% | — | — | -43.32% | -68.17% |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · USD · M
Explore more Health Sciences Group, Inc. data
About Health Sciences Group, Inc. (HESG) Income Statement
Health Sciences Group, Inc. (HESG) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2012, HESG reported revenue of $0.00B, gross profit of $0.00B (gross margin 7.04%), and net income of ($0.00B) — a net profit margin of -15.20%.
Frequently asked questions
HESG · 4 questionsHealth Sciences Group, Inc. (HESG) reported revenue of $0.00B for 2012, up 496.0% year-over-year.
HESG revenueHESG salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15